Study S000208

Effect of Glucagon-like Peptide 1 (GLP1) Receptor Agonists on Mental Health in Patients With Obesity and Type 2 Diabetes (T2D): a Mixed Methods Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05492305
Study type: OBSERVATIONAL
Status: UNKNOWN
Enrollment: 20
Start: 2022-09
Primary completion: 2023-06
Lead sponsor: King's College London
Conditions: Diabetes Mellitus; Obesity; Mental Health Issue
Interventions: DRUG:GLP-1 receptor agonist
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

subjective effect of GLP1 receptor agonist on mental health [12-16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.